Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02521090
Title EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

glioblastoma

gliosarcoma

Therapies

EGFRBi-armed autologous activated T cells

Age Groups: adult
Covered Countries


No variant requirements are available.